Genesis IBRC P/B Ratio
Genesis IBRC (GENESIS) P/B ratio is 9.06 (High), book value per share ₹7.69 vs Healthcare average P/B of -0.94 — Very High - Significant premium, high growth expectations or speculative. Compare with GENESIS DCF valuation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2018)
Valuation Signal
Sector Context
GENESIS P/B Ratio — Valuation Insights & Book Value Analysis
Genesis IBRC price-to-book ratio interpretation, valuation status and historical context — current P/B 9.06 (High). View GENESIS price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 9.06, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1108.0% above historical average
- Trading at premium to sector average PB of -0.94
Genesis IBRC P/B Ratio Historical Trend
GENESIS annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Genesis IBRC share price today.
GENESIS Historical P/B Ratio — Book Value Per Share & Year-End Price
Genesis IBRC annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2018 | 0.75 | ₹7.69 | ₹5.80 | ₹10 | Low |
GENESIS vs Healthcare Peers — P/B Ratio Comparison
Genesis IBRC P/B 9.06 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |